Reply: Surgery vs chemoRT for locally advanced operable head and neck cancers

por Soo, K C, Wee, J, Tan, E H
Publicado 2006

Getting ‘Smad' about obesity and diabetes

por Tan, C K, Chong, H C, Tan, E H P, Tan, N S
Publicado 2012

A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer

por Tan, S-B, Machin, D, Tai, B-C, Foo, K-F, Tan, E-H
Publicado 2002

The validation study on a three-dimensional burn estimation smart-phone application: accurate, free and fast?

por Cheah, A. K. W., Kangkorn, T., Tan, E. H., Loo, M. L., Chong, S. J.
Publicado 2018

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma

por Toh, C-K, Heng, D, Ong, Y-K, Leong, S-S, Wee, J, Tan, E-H
Publicado 2005

Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients

por Lim, S-T, Wong, E-H, Chuah, K-L, Leong, S-S, Lim, W-T, Tay, M-H, Toh, C-K, Tan, E-H
Publicado 2005

Quick-FLIC: validation of a short questionnaire for assessing quality of life of cancer patients

por Cheung, Y-B, Goh, C, Wong, L-C, Ng, G-Y, Lim, W-T, Leong, S-S, Tan, E-H, Khoo, K-S
Publicado 2004

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison

por Soo, K-C, Tan, E-H, Wee, J, Lim, D, Tai, B-C, Khoo, M-L, Goh, C, Leong, S-S, Tan, T, Fong, K-W, Lu, P, See, A, Machin, D
Publicado 2005

Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation

por Toh, H C, Chia, W K, Sun, L, Thng, C H, Soe, Y, Phoon, Y P, Yap, S P, Lim, W T, Tai, W M, Hee, S W, Tan, S H, Leong, S S, Tan, E H
Publicado 2011

A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer

por Tan, E.-H., Ramlau, R., Pluzanska, A., Kuo, H.-P., Reck, M., Milanowski, J., Au, J. S.-K., Felip, E., Yang, P.-C., Damyanov, D., Orlov, S., Akimov, M., Delmar, P., Essioux, L., Hillenbach, C., Klughammer, B., McLoughlin, P., Baselga, J.
Publicado 2010

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

por Paz-Ares, L., Tan, E.-H., O’Byrne, K., Zhang, L., Hirsh, V., Boyer, M., Yang, J.C.-H., Mok, T., Lee, K. H., Lu, S., Shi, Y., Lee, D. H., Laskin, J., Kim, D.-W., Laurie, S. A., Kölbeck, K., Fan, J., Dodd, N., Märten, A., Park, K.
Publicado 2017